We prepared 1-(4'-azido-2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)cytosine (10) and its hydrochloride salt (11) as potential antiviral agents based on the favorable antiviral profiles of 4'-substituted nucleosides. Compounds 10 and 11 were synthesized from 1,3,5-O-tribenzoyl-2-deoxy-2-fluoro-D-arabinofuranoside in multiple steps, and their structures were unequivocally established by IR, (1)H NMR, (13)C NMR, and (19)F NMR spectroscopy, HRMS, and X-ray crystallography. Compounds 10 and 11 exhibited potent anti-HIV-1 activity (EC(50): 0.3 and 0.13 nM, respectively) without significant cytotoxicity in concentrations up to 100 μM. Compound 11 exhibited extremely potent anti-HIV activity against NL4-3 (wild-type), NL4-3 (K101E), and RTMDR viral strains, with EC(50) values of 0.086, 0.15, and 0.11 nM, respectively. Due to the high potency of 11, it was also screened against an NIH Reagent Program NRTI-resistant virus panel containing eleven mutated viral strains and for cytotoxicity against six different human cell lines. The results of this screening indicated that 11 is a novel NRTI that could be developed as an anti-AIDS clinical trial candidate to overcome drug-resistance issues.
We prepared 1-(4'-azido-2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)cytosine (10) and its hydrochloride salt (11) as potential antiviral agents based on the favorable antiviral profiles of n class="Chemical">4'-substituted nucleosides. Compounds 10 and 11 were synthesized from 1,3,5-O-tribenzoyl-2-deoxy-2-fluoro-D-arabinofuranoside in multiple steps, and their structures were unequivocally established by IR, (1)H NMR, (13)C NMR, and (19)F NMR spectroscopy, HRMS, and X-ray crystallography. Compounds 10 and 11 exhibited potent anti-HIV-1 activity (EC(50): 0.3 and 0.13 nM, respectively) without significant cytotoxicity in concentrations up to 100 μM. Compound 11 exhibited extremely potent anti-HIV activity against NL4-3 (wild-type), NL4-3 (K101E), and RTMDR viral strains, with EC(50) values of 0.086, 0.15, and 0.11 nM, respectively. Due to the high potency of 11, it was also screened against an NIH Reagent Program NRTI-resistant virus panel containing eleven mutated viral strains and for cytotoxicity against six different human cell lines. The results of this screening indicated that 11 is a novel NRTI that could be developed as an anti-AIDS clinical trial candidate to overcome drug-resistance issues.
Authors: H Ohrui; S Kohgo; K Kitano; S Sakata; E Kodama; K Yoshimura; M Matsuoka; S Shigeta; H Mitsuya Journal: J Med Chem Date: 2000-11-16 Impact factor: 7.446
Authors: David B Smith; Joseph A Martin; Klaus Klumpp; Stewart J Baker; Peter A Blomgren; Rene Devos; Caroline Granycome; Julie Hang; Christopher J Hobbs; Wen-Rong Jiang; Carl Laxton; Sophie Le Pogam; Vincent Leveque; Han Ma; Graham Maile; John H Merrett; Arkadius Pichota; Keshab Sarma; Mark Smith; Steven Swallow; Julian Symons; David Vesey; Isabel Najera; Nick Cammack Journal: Bioorg Med Chem Lett Date: 2007-02-04 Impact factor: 2.823
Authors: Keduo Qian; Donglei Yu; Chin-Ho Chen; Li Huang; Susan L Morris-Natschke; Theodore J Nitz; Karl Salzwedel; Mary Reddick; Graham P Allaway; Kuo-Hsiung Lee Journal: J Med Chem Date: 2009-05-28 Impact factor: 7.446
Authors: Maqbool A Siddiqui; Stephen H Hughes; Paul L Boyer; Hiroaki Mitsuya; Que N Van; Clifford George; Stefan G Sarafinanos; Victor E Marquez Journal: J Med Chem Date: 2004-10-07 Impact factor: 7.446
Authors: Prem L Sharma; Viktoria Nurpeisov; Brenda Hernandez-Santiago; Thierry Beltran; Raymond F Schinazi Journal: Curr Top Med Chem Date: 2004 Impact factor: 3.295
Authors: David B Smith; Genadiy Kalayanov; Christian Sund; Anna Winqvist; Tatiana Maltseva; Vincent J-P Leveque; Sonal Rajyaguru; Sophie Le Pogam; Isabel Najera; Kurt Benkestock; Xiao-Xiong Zhou; Ann C Kaiser; Hans Maag; Nick Cammack; Joseph A Martin; Steven Swallow; Nils Gunnar Johansson; Klaus Klumpp; Mark Smith Journal: J Med Chem Date: 2009-05-14 Impact factor: 7.446
Authors: Francesc X Ruiz; Anthony Hoang; Christopher R Dilmore; Jeffrey J DeStefano; Eddy Arnold Journal: Drug Discov Today Date: 2022-02-23 Impact factor: 8.369
Authors: Hang Ren; Haoyun An; Paul J Hatala; William C Stevens; Jingchao Tao; Baicheng He Journal: Beilstein J Org Chem Date: 2015-12-09 Impact factor: 2.883